Form 8-K · Current report
Martin Marietta Materials 8-K, filed Aug 10, 2026
- Filed
- CIK
- 0000916076
- Accession no.
- 0001193125-26-341412
Summary
Martin Marietta Materials has received all necessary regulatory approvals for its acquisition of Lhoist North America from LNA Holding SRL, and expects the transaction to close in the third quarter of 2026. The two companies entered the Securities Sale Agreement on June 27, 2026.
Key points
- Martin Marietta Materials and LNA Holding SRL entered a Securities Sale Agreement on June 27, 2026 under which Martin Marietta will acquire all outstanding equity interests in Lhoist North America, Inc., a wholly owned subsidiary of LNA Holding.
- Martin Marietta announced on August 5, 2026 that it had received all necessary regulatory approvals for the transaction.
- The transaction remains subject to customary closing conditions and is expected to close in the third quarter of 2026.
- Audited Lhoist North America financial statements for 2025 and 2024, unaudited statements as of June 30, 2026, and unaudited pro forma combined statements were filed as exhibits; Forvis Mazars LLP was LNA's independent auditor.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events Acquisition of Lhoist North America, Inc. As previously disclosed, on June 27, 2026, Martin Marietta Materials, Inc., a North Carolina corporation (the “Company”), entered into a Securities Sale Agreement (the “Securities Sale Agreement”) with LNA Holding SRL (“LNA Holding”), a société à responsabilité limitée organized under the laws of Belgium, pursuant to which the Company will acquire all of the outstanding equity interests in Lhoist North America, Inc. (“LNA”), a wholly-owned direct subsidiary of LNA Holding (such transaction, the “LNA Transaction”). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.